(Q41846031)

English

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.

scientific article published on 3 April 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

inflammatory bowel diseases

0 references

corrigendum / erratum

Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.

0 references

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Nathaniel R West

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Krista Adelmann

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

26

object named as

Fiona Powrie

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Gerhard Müller-Newen

18

object named as

Gerhard Müller-Newen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

author name string

Ahmed N Hegazy

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Benjamin M J Owens

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Samuel J Bullers

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Bryan Linggi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Sofia Buonocore

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Margherita Coccia

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Sébastien This

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Matthias Friedrich

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Grigory Ryzhakov

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Frédéric Baribaud

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Carrie Brodmerkel

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Constanze Cieluch

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Nahid Rahman

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Raymond J Owens

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Anja A Kühl

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Scott E Plevy

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Oxford IBD Cohort Investigators

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Satish Keshav

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

language of work or name

0 references

publication date

3 April 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Nature Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

579-589

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

https://scigraph.springernature.com/pub.10.1038/nm.4307

0 references

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

The genetic background of inflammatory bowel disease: from correlation to causality.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Immunopathogenesis of IBD: current state of the art.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

CD11c(+) monocyte/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Inflammation, Innate Immunity, and the Intestinal Stromal Cell Niche: Opportunities and Challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Lymph node fibroblastic reticular cells in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Infection risk associated with anti-TNF-α agents: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Management of inflammatory bowel disease in poor responders to infliximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

The alarmin IL-33 promotes regulatory T-cell function in the intestine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Unique lamina propria stromal cells imprint the functional phenotype of mucosal dendritic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Cytokines in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Adverse events in IBD: to stop or continue immune suppressant and biologic treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Tailoring anti-TNF therapy in IBD: drug levels and disease activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

The enigmatic cytokine oncostatin m and roles in disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Extraintestinal manifestations and complications in IBD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Colonic patch and colonic SILT development are independent and differentially regulated events.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Podoplanin: emerging functions in development, the immune system, and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Plasticity and cross-talk of interleukin 6-type cytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Intestinal homeostasis and its breakdown in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

A receptor fusion protein for the inhibition of murine oncostatin M.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Essential function of oncostatin m in nociceptive neurons of dorsal root ganglia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

6 June 2018

Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Therapeutic targeting of the oncostatin M receptor-β prevents inflammatory heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

CD90(+) Stromal Cells are Non-Professional Innate Immune Effectors of the Human Colonic Mucosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Inflammation recapitulates the ontogeny of lymphoid stromal cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

A characteristic subset of psoriasis-associated genes is induced by oncostatin-M in reconstituted epidermis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Targeted disruption of oncostatin M receptor results in altered hematopoiesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420447

18 August 2018

Adenoviral transfer of the murine oncostatin M gene suppresses dextran-sodium sulfate-induced colitis

1 reference

https://api.crossref.org/works/10.1038%2FNM.4307

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling

1 reference

https://api.crossref.org/works/10.1038%2FNM.4307

7 January 2021

based on heuristic

inferred from DOI database lookup

Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1 , and TNF- Recapitulates Some Features of Psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FNM.4307

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncostatin M Secreted by Skin Infiltrating T Lymphocytes Is a Potent Keratinocyte Activator Involved in Skin Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNM.4307

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNM.4307

7 January 2021

based on heuristic

inferred from DOI database lookup

High resolution colonoscopy in live mice

1 reference

https://api.crossref.org/works/10.1038%2FNM.4307

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis

1 reference

https://api.crossref.org/works/10.1038%2FNM.4307

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/28368383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NM.4307

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28368383%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41846031&oldid=1784938771"